Clinical Trial Update: Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health) [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the effects of CagriSema, Cagrilintide, and Semaglutide on muscle health in obesity; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CagriSema (cagrilintide/semaglutide)
• Cagrilintide (cagrilintide)
• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 1 | Status: NOT_YET_RECRUITING